6-Year Risk of Developing Lung Cancer in Spain: Analysis by Autonomous Communities

dc.contributor.authorTravier, Noémie
dc.contributor.authorFu Balboa, Marcela
dc.contributor.authorRomaguera, Amparo
dc.contributor.authorMartín-Cantera, Carlos
dc.contributor.authorFernández Muñoz, Esteve
dc.contributor.authorVidal, Carmen
dc.contributor.authorGarcía Martínez, Montserrat
dc.contributor.authorLUCAPREV research group
dc.date.accessioned2026-01-12T16:23:21Z
dc.date.available2026-01-12T16:23:21Z
dc.date.issued2020-05-11
dc.date.updated2026-01-12T16:23:21Z
dc.description.abstractIntroduction: Lung cancer screening with low-dose computed tomography (LDCT) has been proposed as a strategy to reduce lung cancer mortality. Since LDCT has side effects there is a need to carefully select the target population for screening programmes. Because in Spain health competences are transferred to the seventeen Autonomous Communities (ACs), the present paper aims to identify individuals at high risk of developing lung cancer in the different ACs. Methods: We used the 2011-2012 data of the Spanish National Interview Health Survey (n=21,006) to estimate the proportion of individuals at high risk of developing lung cancer using a 6-year prediction model (PLCOm2012). This proportion was then extrapolated into absolute figures for the Spanish population, using the population census data of 2018 from the National Institute of Statistics. Results: The proportion of individuals aged 50-74 with a risk of lung cancer ≥2% was 9.5% (15.9% in men, 3.5% in women). This proportion ranged from 6.6% in Región de Murcia to 12.7% in Andalucía and 13.0% in Extremadura. When extrapolated to the Spanish population, it was estimated that a total of 1,341,483 individuals may have a 6-year risk of lung cancer ≥2%. Conclusions: The present study is the first one that evaluated the number of individuals at high risk of developing lung cancer in the different Spanish ACs using a prediction model and selecting people with a 6-year risk ≥2%. Further studies should assess the cost and effectiveness associated to the implementation of a lung cancer screening programme to such population.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec706523
dc.identifier.issn0300-2896
dc.identifier.pmid35699029
dc.identifier.urihttps://hdl.handle.net/2445/225317
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.arbr.2020.03.033
dc.relation.ispartofArchivos de Bronconeumologia, 2020, vol. 57, num.8, p. 521-527
dc.relation.urihttps://doi.org/10.1016/j.arbr.2020.03.033
dc.rightscc-by-nc-nd (c) Elsevier, 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.classificationEspanya
dc.subject.classificationDiagnòstic
dc.subject.classificationTomografia
dc.subject.classificationCàncer de pulmó
dc.subject.otherSpain
dc.subject.otherDiagnosis
dc.subject.otherTomography
dc.subject.otherLung cancer
dc.title6-Year Risk of Developing Lung Cancer in Spain: Analysis by Autonomous Communities
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
234090.pdf
Mida:
370.72 KB
Format:
Adobe Portable Document Format